日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cancer and COVID-19: A review of immune insights and partnerships to inform public health strategy

癌症与新冠肺炎:免疫学见解与合作综述,为公共卫生策略提供信息

Hempel, Heidi; Xue, Huijing; La Shu, Shin; Jain, Shweta; Kemp, Troy J; Pinto, Ligia A

Development of HPV 35 serology assays for assessment of immune responses to HPV 35 after infection and vaccination

开发HPV 35血清学检测方法,用于评估感染和接种疫苗后对HPV 35的免疫反应。

Kim, Kathleen; Porras, Carolina; Kreimer, Aimee R; Hempel, Heidi; Kemp, Troy J; Lowy, Douglas R; Pinto, Ligia A

Development and calibration of an HPV serology secondary standard for measuring antibody responses in HPV vaccine trials: a preliminary report

HPV疫苗试验中用于测量抗体反应的HPV血清学二级标准的开发和校准:初步报告

Kemp, Troy J; Wilkinson, Dianna E; Panicker, Gitika; Eklund, Carina; Miller, Cheryl; Dillner, Joakim; Beddows, Simon; Unger, Elizabeth R; Pinto, Ligia A

Durability of immunogenicity at 5 years after a single dose of human papillomavirus vaccine compared with two doses in Tanzanian girls aged 9-14 years: results of the long-term extension of the DoRIS randomised trial

坦桑尼亚9-14岁女孩单剂人乳头瘤病毒疫苗与两剂人乳头瘤病毒疫苗接种后5年免疫原性的持久性比较:DoRIS随机试验长期扩展研究结果

Watson-Jones, Deborah; Changalucha, John; Maxwell, Caroline; Whitworth, Hilary; Mutani, Paul; Kemp, Troy J; Kamala, Beatrice; Indangasi, Jackton; Constantine, George; Hashim, Ramadhan; Mwanzalima, David; Wiggins, Rebecca; Mmbando, Devis; Connor, Nicholas; Pavon, Miquel A; Lowe, Brett; Kapiga, Saidi; Mayaud, Philippe; de Sanjosé, Silvia; Dillner, Joakim; Hayes, Richard J; Lacey, Charles J; Pinto, Ligia; Baisley, Kathy

Immunogenicity of one and two doses of Gardasil®9 in Tanzanian girls in the DoRIS Trial

在多里森试验中,坦桑尼亚女孩接种一剂和两剂加卫苗®9的免疫原性

Kemp, Troy J; Baisley, Kathy; Changalucha, John; Indangasi, Jackton; Whitworth, Hilary; Lacey, Charles J; Mwanzalima, David; Hashim, Ramadhan; Kapiga, Saidi; Hayes, Richard J; Pinto, Ligia A; Watson-Jones, Deborah

Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters

癌症患者多次接种新冠疫苗加强针后体内循环的SARS-CoV-2刺突蛋白IgG抗体反应

Xue, Huijing; Kemp, Troy J; North, Hayley; Roche, Nancy V; Hickey, Thomas E; Pinto, Ligia A

Non-steroidal anti-inflammatory drug use and inflammatory markers associated with gallbladder dysplasia: A case-control analysis within a series of patients undergoing cholecystectomy

非甾体类抗炎药的使用与胆囊发育不良相关的炎症标志物:一项针对接受胆囊切除术患者的病例对照分析

Rosa, Lorena; Cook, Paz; Pfeiffer, Ruth M; Kemp, Troy J; Hildesheim, Allan; Pehlivanoglu, Burcin; Adsay, Volkan; Bellolio, Enrique; Araya, Juan Carlos; Pinto, Ligia; Ferreccio, Catterina; Aguayo, Gloria; Viñuela, Eduardo; Koshiol, Jill

Humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients undergoing treatment

癌症患者接受治疗后接种第二剂新冠病毒mRNA疫苗的体液免疫反应

Dang, Christine M; Kemp, Troy J; Roche, Nancy; Haynesworth, Katarzyna; Loftus, Sarah A; Borski, Benjamin J; El Bakouny, Ziad; Labaki, Chris; Lee, Gwo-Shou Mary; Trowbridge, Rachel; Strauss, Sarah; Hughes, Melissa E; Lin, Nancy U; Choueiri, Toni K; Pinto, Ligia A

Neutralizing antibody responses to the primary series of a COVID-19 mRNA vaccine in the cancer cohort under active treatment

接受积极治疗的癌症患者群体对 COVID-19 mRNA 疫苗初次免疫接种后的中和抗体反应

Xue, Huijing; Kemp, Troy J; Li, Chenglei; Roche, Nancy V; Bakouny, Ziad; Labaki, Chris; Lee, Guo-Shou Mary; Trowbridge, Rachel; Strauss, Sarah; Hughes, Melissa E; Lin, Nancy U; Choueiri, Toni K; Pinto, Ligia A

Immunogenicity and safety of an Escherichia coli-produced bivalent human papillomavirus vaccine (Cecolin) in girls aged 9-14 years in Ghana and Bangladesh: a randomised, controlled, open-label, non-inferiority, phase 3 trial

在加纳和孟加拉国,一项随机、对照、开放标签、非劣效性3期临床试验评估了由大肠杆菌生产的二价人乳头瘤病毒疫苗(Cecolin)在9-14岁女孩中的免疫原性和安全性。

Agbenyega, Tsiri; Schuind, Anne E; Adjei, Samuel; Antony, Kalpana; Aponte, John J; Buabeng, Patrick B Y; Clemens, John D; Hossain, Lokman; Kemp, Troy J; Mercer, Laina D; Pinto, Ligia A; Qadri, Firdausi; Sukraw, Kristen; Bhat, Niranjan; Zaman, Khalequ